Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

Completed

Conditions studied: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)

In brief

This clinical trial studies genetic biomarkers from saliva samples in patients with Ewing sarcoma. Studying samples of saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.

Key facts

Study ID

NCT01876303

Run by

Children's Oncology Group

People needed

1650

Starts

2012-12-01

Last updated by the study team

2016-07-14

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The patient is enrolled on ACCRN07
• The patient has a diagnosis of Ewing Sarcoma (International Classification of Diseases [ICD] code morphology 9260; topography C40.0-C41.9, C76.0-C76.8, C80.9) and is registered with Children's Oncology Group (COG) by a North American member institution
• The patient must be diagnosed with Ewing sarcoma between December 24, 2007 and December 31, 2015
• The patient must have at least one biological parent alive and willing to participate
• All questionnaire respondents must understand English or Spanish
• Concomitant treatment on a therapeutic trial is not required

Where it is running

• Children's Oncology Group — Monrovia, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.